Myovant Sciences Ltd. Restricted Cash
Myovant Sciences Ltd. had Restricted Cash of $6.17 million as of 2022-12-31, per its 10-Q filed 2023-01-26.
Discontinued › Balance Sheet › Assets
us-gaap:RestrictedCash · last filed 2023-01-26
- 2022-12-31: Restricted Cash $6.17M.
- 2022-09-30: Restricted Cash $10.87M.
- 2022-06-30: Restricted Cash $10.71M.
- 2022-03-31: Restricted Cash $10.10M.
| Period end | Restricted Cash |
|---|---|
| 2022-12-31 | $6.17M 10-Q · filed 2023-01-26 |
| 2022-09-30 | $10.87M 10-Q · filed 2022-10-26 |
| 2022-06-30 | $10.71M 10-Q · filed 2022-07-27 |
| 2022-03-31 | $10.10M 10-K · filed 2022-05-11 |
| 2021-12-31 | $10.10M 10-Q · filed 2023-01-26 |
| 2021-09-30 | $10.10M 10-Q · filed 2022-10-26 |
| 2021-06-30 | $9.09M 10-Q · filed 2022-07-27 |
| 2021-03-31 | $2.99M 10-K · filed 2022-05-11 |
| 2020-12-31 | $2.99M 10-Q · filed 2022-01-26 |
| 2020-09-30 | $1.99M 10-Q · filed 2021-10-26 |
| 2020-06-30 | $1.37M 10-Q · filed 2021-07-28 |
| 2020-03-31 | $1.37M 10-K · filed 2022-05-11 |
| 2019-12-31 | $1.37M 10-Q · filed 2021-02-11 |
| 2019-09-30 | $1.37M 10-Q · filed 2020-11-12 |
| 2019-03-31 | $1.13M 10-K · filed 2021-05-11 |